Shandong Teamgene Technology Co., Ltd. (SHA:603151)
China · Delayed Price · Currency is CNY 15.75
+0.15 (0.96%)
Aug 24, 2026, 4:00 PM EDT
SHA:603151 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 5,988 | 5,609 | 2,480 | 1,564 | 1,613 | 2,006 |
Other Revenue | -5.73 | 90.01 | 61.21 | 82.92 | 45.44 | 28.99 |
| 5,982 | 5,699 | 2,542 | 1,647 | 1,658 | 2,035 | |
Revenue Growth | 48.11% | 124.24% | 54.36% | -0.71% | -18.50% | 18.05% |
Cost of Revenue | 5,611 | 5,278 | 2,308 | 1,433 | 1,432 | 1,780 |
Gross Profit | 371.63 | 421.39 | 233.71 | 213.38 | 226.4 | 254.97 |
Selling, General & Admin | 159.16 | 124.17 | 95.8 | 79.02 | 64.62 | 59.86 |
Research & Development | 62.43 | 57.8 | 41.55 | 31.84 | 33.7 | 39.76 |
Other Operating Expenses | 7.45 | 7.49 | 3.73 | 2.47 | 2.04 | 0.73 |
Operating Expenses | 258.19 | 262.33 | 163.53 | 121.69 | 103.69 | 100.01 |
Operating Income | 113.44 | 159.06 | 70.19 | 91.69 | 122.72 | 154.96 |
Interest Expense | -17.1 | -26.67 | -7.41 | -0.83 | -1.61 | -0.85 |
Interest & Investment Income | 0.71 | 3.25 | 1.54 | 9.31 | 3.39 | 2.11 |
Other Non Operating Income (Expenses) | -25.01 | -1.62 | -4.35 | -0.55 | -0.27 | 14.17 |
EBT Excluding Unusual Items | 72.05 | 134.03 | 59.96 | 99.63 | 124.22 | 170.38 |
Gain (Loss) on Sale of Investments | - | - | -1.03 | - | - | - |
Gain (Loss) on Sale of Assets | -0.66 | -0.36 | - | -1.03 | 0.03 | 0.74 |
Asset Writedown | -40.35 | -0.86 | -0.22 | - | - | - |
Other Unusual Items | -4.32 | -3.21 | 4.56 | 1.2 | 13.51 | 0.07 |
Pretax Income | 27.18 | 130.06 | 63.27 | 99.79 | 137.76 | 171.18 |
Income Tax Expense | 28.96 | 30.87 | 11.75 | 16.08 | 17.94 | 25.12 |
Earnings From Continuing Operations | -1.78 | 99.19 | 51.53 | 83.71 | 119.82 | 146.07 |
Minority Interest in Earnings | 47.71 | 11.66 | -1.4 | 0.18 | 0.61 | -0.24 |
Net Income | 45.92 | 110.85 | 50.13 | 83.89 | 120.43 | 145.82 |
Net Income to Common | 45.92 | 110.85 | 50.13 | 83.89 | 120.43 | 145.82 |
Net Income Growth | -49.62% | 121.12% | -40.24% | -30.34% | -17.41% | 30.25% |
Shares Outstanding (Basic) | 171 | 170 | 168 | 168 | 133 | 126 |
Shares Outstanding (Diluted) | 172 | 170 | 168 | 168 | 133 | 126 |
Shares Change | 2.08% | 1.11% | -0.01% | 26.33% | 5.55% | 5.85% |
EPS (Basic) | 0.27 | 0.65 | 0.30 | 0.50 | 0.91 | 1.16 |
EPS (Diluted) | 0.27 | 0.65 | 0.30 | 0.50 | 0.91 | 1.16 |
EPS Growth | -50.64% | 118.70% | -40.24% | -44.86% | -21.76% | 23.05% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -62.11 | -754.03 | -224.13 | -314.52 | -113.34 | 34.19 |
Free Cash Flow Per Share | -0.36 | -4.44 | -1.33 | -1.87 | -0.85 | 0.27 |
Dividend Per Share | 0.150 | 0.200 | 0.150 | 0.200 | 0.500 | - |
Dividend Growth | -25.00% | 33.33% | -25.00% | -60.00% | 66.67% | - |
Gross Margin | 6.21% | 7.39% | 9.20% | 12.96% | 13.65% | 12.53% |
Operating Margin | 1.90% | 2.79% | 2.76% | 5.57% | 7.40% | 7.61% |
Profit Margin | 0.77% | 1.94% | 1.97% | 5.10% | 7.26% | 7.17% |
Free Cash Flow Margin | -1.04% | -13.23% | -8.82% | -19.10% | -6.83% | 1.68% |
EBITDA | 191.13 | 225.69 | 118.99 | 118.36 | 135.15 | 164.99 |
EBITDA Margin | 3.19% | 3.96% | 4.68% | 7.19% | 8.15% | 8.11% |
D&A For EBITDA | 77.7 | 66.62 | 48.8 | 26.67 | 12.44 | 10.04 |
EBIT | 113.44 | 159.06 | 70.19 | 91.69 | 122.72 | 154.96 |
EBIT Margin | 1.90% | 2.79% | 2.76% | 5.57% | 7.40% | 7.61% |
Effective Tax Rate | 106.56% | 23.73% | 18.57% | 16.11% | 13.02% | 14.67% |
Revenue as Reported | 3,307 | 5,699 | 2,542 | 1,647 | 1,658 | 2,035 |
Advertising Expenses | - | 2.27 | 2.29 | 5.47 | 2.83 | 5.27 |